Anthony Petrone
Stock Analyst at Mizuho
(3.74)
# 724
Out of 4,937 analysts
191
Total ratings
48.91%
Success rate
7.56%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HAE Haemonetics | Maintains: Outperform | $90 → $70 | $53.99 | +29.65% | 15 | Aug 8, 2025 | |
| LNTH Lantheus Holdings | Maintains: Outperform | $120 → $70 | $57.20 | +22.38% | 6 | Aug 7, 2025 | |
| RMD ResMed | Maintains: Outperform | $270 → $290 | $283.90 | +2.15% | 17 | Aug 1, 2025 | |
| TFX Teleflex | Maintains: Neutral | $130 → $135 | $118.41 | +14.01% | 9 | Aug 1, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $87 → $95 | $78.35 | +21.25% | 9 | Jul 25, 2025 | |
| ABT Abbott Laboratories | Maintains: Neutral | $140 → $135 | $134.28 | +0.54% | 6 | Jul 18, 2025 | |
| COO The Cooper Companies | Maintains: Outperform | $105 → $90 | $70.29 | +28.04% | 15 | Jul 16, 2025 | |
| STAA STAAR Surgical Company | Maintains: Neutral | $17 → $18 | $27.26 | -33.97% | 8 | Jul 16, 2025 | |
| MDT Medtronic | Maintains: Outperform | $98 → $100 | $92.88 | +7.67% | 7 | Jul 16, 2025 | |
| HOLX Hologic | Maintains: Outperform | $65 → $70 | $68.06 | +2.85% | 9 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $58 → $70 | $34.83 | +100.98% | 7 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $12 | $12.28 | -2.28% | 3 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $100 | $78.86 | +26.81% | 2 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $65 | $54.23 | +19.86% | 2 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $200 → $175 | $84.65 | +106.73% | 10 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $2 | $0.50 | +303.71% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $20 | $11.23 | +78.09% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $60 | $40.99 | +46.38% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $120 | $85.75 | +39.94% | 9 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $58 | $47.85 | +21.21% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $60 | $48.85 | +22.82% | 8 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $110 | $103.14 | +6.65% | 8 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $14 | $16.52 | -15.25% | 6 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $105 | $72.00 | +45.83% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 | $79.14 | +215.90% | 6 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $7.02 | +99.43% | 4 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $350 → $390 | $470.08 | -17.04% | 6 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $63 → $67 | $92.54 | -27.60% | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $200 → $175 | $99.26 | +76.30% | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $30 → $25 | $9.48 | +163.71% | 3 | May 13, 2020 |
Haemonetics
Aug 8, 2025
Maintains: Outperform
Price Target: $90 → $70
Current: $53.99
Upside: +29.65%
Lantheus Holdings
Aug 7, 2025
Maintains: Outperform
Price Target: $120 → $70
Current: $57.20
Upside: +22.38%
ResMed
Aug 1, 2025
Maintains: Outperform
Price Target: $270 → $290
Current: $283.90
Upside: +2.15%
Teleflex
Aug 1, 2025
Maintains: Neutral
Price Target: $130 → $135
Current: $118.41
Upside: +14.01%
Edwards Lifesciences
Jul 25, 2025
Maintains: Outperform
Price Target: $87 → $95
Current: $78.35
Upside: +21.25%
Abbott Laboratories
Jul 18, 2025
Maintains: Neutral
Price Target: $140 → $135
Current: $134.28
Upside: +0.54%
The Cooper Companies
Jul 16, 2025
Maintains: Outperform
Price Target: $105 → $90
Current: $70.29
Upside: +28.04%
STAAR Surgical Company
Jul 16, 2025
Maintains: Neutral
Price Target: $17 → $18
Current: $27.26
Upside: -33.97%
Medtronic
Jul 16, 2025
Maintains: Outperform
Price Target: $98 → $100
Current: $92.88
Upside: +7.67%
Hologic
Jul 16, 2025
Maintains: Outperform
Price Target: $65 → $70
Current: $68.06
Upside: +2.85%
Jul 16, 2025
Maintains: Outperform
Price Target: $58 → $70
Current: $34.83
Upside: +100.98%
Jul 16, 2025
Maintains: Neutral
Price Target: $13 → $12
Current: $12.28
Upside: -2.28%
Jul 16, 2025
Maintains: Outperform
Price Target: $95 → $100
Current: $78.86
Upside: +26.81%
Jun 13, 2025
Maintains: Outperform
Price Target: $60 → $65
Current: $54.23
Upside: +19.86%
Apr 16, 2025
Maintains: Outperform
Price Target: $200 → $175
Current: $84.65
Upside: +106.73%
Apr 10, 2025
Initiates: Outperform
Price Target: $2
Current: $0.50
Upside: +303.71%
Apr 10, 2025
Initiates: Neutral
Price Target: $20
Current: $11.23
Upside: +78.09%
Apr 10, 2025
Initiates: Outperform
Price Target: $60
Current: $40.99
Upside: +46.38%
Mar 28, 2025
Maintains: Outperform
Price Target: $115 → $120
Current: $85.75
Upside: +39.94%
Mar 6, 2025
Maintains: Buy
Price Target: $54 → $58
Current: $47.85
Upside: +21.21%
Feb 26, 2025
Maintains: Outperform
Price Target: $70 → $60
Current: $48.85
Upside: +22.82%
Oct 24, 2024
Maintains: Outperform
Price Target: $100 → $110
Current: $103.14
Upside: +6.65%
Jun 20, 2024
Maintains: Buy
Price Target: $12 → $14
Current: $16.52
Upside: -15.25%
May 1, 2024
Maintains: Buy
Price Target: $110 → $105
Current: $72.00
Upside: +45.83%
Mar 27, 2024
Maintains: Buy
Price Target: $250
Current: $79.14
Upside: +215.90%
Mar 1, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $7.02
Upside: +99.43%
Jan 25, 2024
Maintains: Neutral
Price Target: $350 → $390
Current: $470.08
Upside: -17.04%
Aug 3, 2023
Downgrades: Hold
Price Target: $63 → $67
Current: $92.54
Upside: -27.60%
Nov 5, 2021
Maintains: Buy
Price Target: $200 → $175
Current: $99.26
Upside: +76.30%
May 13, 2020
Maintains: Hold
Price Target: $30 → $25
Current: $9.48
Upside: +163.71%